Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Diseases | 4 | 2005 | 190 | 0.420 |
Why?
|
| Fluorescein Angiography | 4 | 2019 | 148 | 0.290 |
Why?
|
| Eye Infections, Bacterial | 2 | 2000 | 96 | 0.270 |
Why?
|
| Fundus Oculi | 5 | 2019 | 69 | 0.260 |
Why?
|
| Laser Coagulation | 2 | 2005 | 141 | 0.260 |
Why?
|
| Visual Acuity | 5 | 2019 | 861 | 0.240 |
Why?
|
| Retinal Vessels | 1 | 2005 | 82 | 0.240 |
Why?
|
| Endophthalmitis | 2 | 2004 | 82 | 0.220 |
Why?
|
| Retinal Detachment | 3 | 2019 | 86 | 0.200 |
Why?
|
| Actinomycetales | 1 | 2000 | 4 | 0.180 |
Why?
|
| Eye Injuries, Penetrating | 1 | 2000 | 22 | 0.170 |
Why?
|
| Eye Foreign Bodies | 1 | 2000 | 16 | 0.170 |
Why?
|
| Actinomycetales Infections | 1 | 2000 | 17 | 0.170 |
Why?
|
| Retinal Perforations | 1 | 2019 | 27 | 0.170 |
Why?
|
| Wound Infection | 1 | 2000 | 66 | 0.170 |
Why?
|
| Retinopathy of Prematurity | 1 | 2019 | 58 | 0.170 |
Why?
|
| Endocarditis, Bacterial | 2 | 2004 | 152 | 0.160 |
Why?
|
| Silicone Oils | 1 | 1998 | 12 | 0.160 |
Why?
|
| Humidity | 1 | 1998 | 28 | 0.160 |
Why?
|
| Silicone Elastomers | 1 | 1998 | 54 | 0.160 |
Why?
|
| Polymethyl Methacrylate | 1 | 1998 | 41 | 0.160 |
Why?
|
| Acrylic Resins | 1 | 1998 | 49 | 0.150 |
Why?
|
| Retinal Neoplasms | 1 | 1999 | 137 | 0.140 |
Why?
|
| Vitreous Body | 3 | 2000 | 116 | 0.140 |
Why?
|
| Choroid Hemorrhage | 1 | 1996 | 1 | 0.140 |
Why?
|
| Plasminogen Activators | 1 | 1996 | 55 | 0.130 |
Why?
|
| Astrocytoma | 1 | 1999 | 326 | 0.130 |
Why?
|
| Retina | 1 | 2019 | 539 | 0.130 |
Why?
|
| Nevus of Ota | 1 | 1995 | 3 | 0.130 |
Why?
|
| Glaucoma, Open-Angle | 1 | 1995 | 41 | 0.130 |
Why?
|
| Ophthalmology | 1 | 1998 | 204 | 0.120 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1996 | 161 | 0.120 |
Why?
|
| Glaucoma, Angle-Closure | 1 | 1994 | 16 | 0.120 |
Why?
|
| Choroid Neoplasms | 1 | 1994 | 45 | 0.120 |
Why?
|
| Optic Nerve Diseases | 1 | 1996 | 111 | 0.120 |
Why?
|
| Retinal Hemorrhage | 1 | 1994 | 24 | 0.120 |
Why?
|
| Vitrectomy | 3 | 2000 | 110 | 0.110 |
Why?
|
| Lenses, Intraocular | 1 | 1998 | 394 | 0.110 |
Why?
|
| Bone Marrow Transplantation | 2 | 1996 | 1755 | 0.110 |
Why?
|
| Blood | 2 | 2005 | 172 | 0.100 |
Why?
|
| Daunorubicin | 1 | 1991 | 314 | 0.090 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 1996 | 1229 | 0.080 |
Why?
|
| Staphylococcal Infections | 1 | 1994 | 679 | 0.080 |
Why?
|
| Rabbits | 4 | 1998 | 1012 | 0.070 |
Why?
|
| Choroid Diseases | 2 | 1996 | 23 | 0.060 |
Why?
|
| Capillary Permeability | 1 | 2005 | 116 | 0.060 |
Why?
|
| Intraocular Pressure | 2 | 1995 | 156 | 0.060 |
Why?
|
| Injections | 2 | 2000 | 286 | 0.050 |
Why?
|
| Metals | 1 | 2000 | 148 | 0.040 |
Why?
|
| Epiretinal Membrane | 1 | 1999 | 15 | 0.040 |
Why?
|
| Choroidal Neovascularization | 1 | 1999 | 30 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 1995 | 4887 | 0.040 |
Why?
|
| Capsulorhexis | 1 | 1998 | 17 | 0.040 |
Why?
|
| Durapatite | 1 | 1998 | 25 | 0.040 |
Why?
|
| Ultrasonography | 2 | 1996 | 1928 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1994 | 5585 | 0.040 |
Why?
|
| Vitreoretinopathy, Proliferative | 1 | 1998 | 6 | 0.040 |
Why?
|
| Triamcinolone | 1 | 1998 | 25 | 0.040 |
Why?
|
| Gentamicins | 1 | 1998 | 111 | 0.040 |
Why?
|
| Hyperplasia | 1 | 1999 | 557 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2000 | 2325 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 1996 | 16640 | 0.030 |
Why?
|
| Fluorouracil | 2 | 1998 | 1989 | 0.030 |
Why?
|
| Choroid | 1 | 1996 | 42 | 0.030 |
Why?
|
| Demyelinating Diseases | 1 | 1996 | 81 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 1998 | 288 | 0.030 |
Why?
|
| Timolol | 1 | 1995 | 9 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 1998 | 341 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 1998 | 294 | 0.030 |
Why?
|
| Male | 8 | 2019 | 127911 | 0.030 |
Why?
|
| Carmustine | 1 | 1996 | 224 | 0.030 |
Why?
|
| Anterior Eye Segment | 1 | 1995 | 34 | 0.030 |
Why?
|
| History, 20th Century | 1 | 1998 | 543 | 0.030 |
Why?
|
| Sclera | 1 | 1995 | 62 | 0.030 |
Why?
|
| Ophthalmic Solutions | 1 | 1995 | 97 | 0.030 |
Why?
|
| Optic Disk | 1 | 1995 | 54 | 0.030 |
Why?
|
| Optic Nerve | 1 | 1996 | 139 | 0.030 |
Why?
|
| Lens Implantation, Intraocular | 1 | 1998 | 340 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 1996 | 16182 | 0.030 |
Why?
|
| Humans | 11 | 2019 | 270014 | 0.030 |
Why?
|
| Reoperation | 1 | 1999 | 1390 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 1998 | 618 | 0.030 |
Why?
|
| Adult | 4 | 2019 | 81690 | 0.030 |
Why?
|
| Ischemia | 1 | 1996 | 399 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 1998 | 1105 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 1998 | 15172 | 0.020 |
Why?
|
| Cisplatin | 2 | 1996 | 2496 | 0.020 |
Why?
|
| Cyclophosphamide | 2 | 1996 | 3242 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 1998 | 1426 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 1996 | 2045 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 1998 | 7342 | 0.020 |
Why?
|
| Middle Aged | 5 | 2019 | 90027 | 0.020 |
Why?
|
| Eye Diseases | 1 | 1991 | 129 | 0.020 |
Why?
|
| Random Allocation | 1 | 1991 | 740 | 0.020 |
Why?
|
| Adolescent | 3 | 2019 | 32646 | 0.020 |
Why?
|
| Disease Progression | 1 | 2019 | 6840 | 0.020 |
Why?
|
| Aged | 3 | 2019 | 73126 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 1996 | 1146 | 0.020 |
Why?
|
| Fibroblasts | 2 | 1991 | 1628 | 0.020 |
Why?
|
| Female | 6 | 2019 | 148480 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2000 | 3160 | 0.020 |
Why?
|
| Cell Division | 1 | 1991 | 2650 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 12952 | 0.020 |
Why?
|
| Animals | 5 | 1998 | 61707 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 1991 | 3523 | 0.020 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2004 | 136 | 0.010 |
Why?
|
| Abscess | 1 | 2004 | 192 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2004 | 288 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 2004 | 183 | 0.010 |
Why?
|
| Aortic Diseases | 1 | 2004 | 192 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 22134 | 0.010 |
Why?
|
| United States | 1 | 1998 | 15776 | 0.010 |
Why?
|
| Aortic Valve Stenosis | 1 | 2004 | 344 | 0.010 |
Why?
|
| Child | 1 | 2019 | 30460 | 0.010 |
Why?
|
| Osseointegration | 1 | 1998 | 19 | 0.010 |
Why?
|
| Drug Implants | 1 | 1998 | 52 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 1996 | 7009 | 0.010 |
Why?
|
| Electroretinography | 1 | 1998 | 126 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1998 | 159 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 1998 | 190 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 1998 | 201 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 39733 | 0.010 |
Why?
|
| Orbit | 1 | 1998 | 209 | 0.010 |
Why?
|
| Scotoma | 1 | 1996 | 16 | 0.010 |
Why?
|
| Mastectomy, Modified Radical | 1 | 1996 | 75 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1998 | 589 | 0.010 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1996 | 82 | 0.010 |
Why?
|
| Visual Fields | 1 | 1996 | 150 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1996 | 822 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 1996 | 344 | 0.010 |
Why?
|
| Methotrexate | 1 | 1996 | 1025 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 3023 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1994 | 12019 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1998 | 2843 | 0.010 |
Why?
|
| Rose Bengal | 1 | 1991 | 16 | 0.010 |
Why?
|
| Cats | 1 | 1991 | 163 | 0.010 |
Why?
|
| Light | 1 | 1991 | 279 | 0.010 |
Why?
|
| Doxorubicin | 1 | 1996 | 3142 | 0.010 |
Why?
|
| Transplantation Conditioning | 1 | 1996 | 2368 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1996 | 4820 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1996 | 9039 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1998 | 5666 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 1991 | 6181 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 1998 | 33690 | 0.000 |
Why?
|